Feb. 3, 2014, 9:09 AM
Jan. 8, 2014, 12:46 PM
Jan. 7, 2014, 6:16 PM
- ArthroCare (ARTC) +10.9% AH enters into a deferred prosecution agreement with the Justice Department which resolves the DOJ investigation regarding allegations of securities and related fraud committed under a previous management team.
- As part of the agreement, ARTC will pay a $30M fine to the DOJ and maintain a compliance program that it must report on annually.
Aug. 5, 2013, 4:17 PM
- ArthroCare (ARTC): Q2 EPS of -$0.27.
- Revenue of $92.1M misses by $1.57M. Shares +6.1% AH. (PR)
Feb. 17, 2012, 2:10 PM
Arthrocare (ARTC -17.8%) shares plunges a day after reporting a substantial Q4 loss attributed largely to hefty charges related to a proposed settlement of certain securities class action suits. Jefferies cuts its stock rating to Hold from Buy and drops its price target to $25 from $32, citing the "new and entirely unexpected" investigation which will preclude an anticipated takeover.| Feb. 17, 2012, 2:10 PM
Nov. 28, 2011, 10:47 AM
ArthroCare (ARTC) tacks on a 9.4% gain after announcing a $74M agreement to settle a class action lawsuit pending against the medical devices firm in relation to securities transactions between Dec. 11, 2007 and Feb. 18, 2009.| Nov. 28, 2011, 10:47 AM